These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9583424)

  • 21. Confounding by drug formulary restriction in pharmacoepidemiologic research.
    Filion KB; Eberg M; Ernst P
    Pharmacoepidemiol Drug Saf; 2016 Mar; 25(3):278-86. PubMed ID: 26648236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjustment for missing confounders in studies based on observational databases: 2-stage calibration combining propensity scores from primary and validation data.
    Lin HW; Chen YH
    Am J Epidemiol; 2014 Aug; 180(3):308-17. PubMed ID: 24966224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Assessment of database results of pharmacist intervention].
    Sabater-Hernández D; Beidas-Soler M; Baena MI; Amariles P; Sáez-Benito L; Martínez-Martínez F; Faus MJ
    Farm Hosp; 2009; 33(3):175-7. PubMed ID: 19712603
    [No Abstract]   [Full Text] [Related]  

  • 24. Performance of instrumental variable methods in cohort and nested case-control studies: a simulation study.
    Uddin MJ; Groenwold RH; de Boer A; Belitser SV; Roes KC; Hoes AW; Klungel OH
    Pharmacoepidemiol Drug Saf; 2014 Feb; 23(2):165-77. PubMed ID: 24306965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Confounders and intermediaries in case-control study designs: a strategy for distinguishing between the two when measured using the same variable.
    Gruneir A; Marras C; Fischer H; Wang X; Gill S; Rochon PA; Anderson GM
    Pharmacoepidemiol Drug Saf; 2011 Mar; 20(3):221-8. PubMed ID: 21351302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The case-time-control design.
    Suissa S
    Epidemiology; 1995 May; 6(3):248-53. PubMed ID: 7619931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guide to interpreting and evaluating the pharmacoepidemiologic literature.
    Hartzema AG
    Ann Pharmacother; 1992 Jan; 26(1):96-8. PubMed ID: 1535003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of confounder in epidemiologic data contaminated by measurement error in covariates.
    Lee PH; Burstyn I
    BMC Med Res Methodol; 2016 May; 16():54. PubMed ID: 27193095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The design of case-control studies: the effect of confounding on sample size requirements.
    Drescher K; Timm J; Jöckel KH
    Stat Med; 1990 Jul; 9(7):765-76. PubMed ID: 2218179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methods to control for unmeasured confounding in pharmacoepidemiology: an overview.
    Uddin MJ; Groenwold RH; Ali MS; de Boer A; Roes KC; Chowdhury MA; Klungel OH
    Int J Clin Pharm; 2016 Jun; 38(3):714-23. PubMed ID: 27091131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequence symmetry analysis in pharmacovigilance and pharmacoepidemiologic studies.
    Lai EC; Pratt N; Hsieh CY; Lin SJ; Pottegård A; Roughead EE; Kao Yang YH; Hallas J
    Eur J Epidemiol; 2017 Jul; 32(7):567-582. PubMed ID: 28698923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study.
    Moride Y; Ducruet T; Boivin JF; Moore N; Perreault S; Zhao S
    Arthritis Res Ther; 2005; 7(2):R333-42. PubMed ID: 15743481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How do we best detect toxic effects of drugs taken during pregnancy? A EuroMap paper.
    Olsen J; Czeizel A; Sørensen HT; Nielsen GL; de Jong van den Berg LT; Irgens LM; Olesen C; Pedersen L; Larsen H; Lie RT; de Vries CS; Bergman U
    Drug Saf; 2002; 25(1):21-32. PubMed ID: 11820910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detecting adverse drug reactions following long-term exposure in longitudinal observational data: The exposure-adjusted self-controlled case series.
    Schuemie MJ; Trifirò G; Coloma PM; Ryan PB; Madigan D
    Stat Methods Med Res; 2016 Dec; 25(6):2577-2592. PubMed ID: 24685766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Should we use a case-crossover design?
    Maclure M; Mittleman MA
    Annu Rev Public Health; 2000; 21():193-221. PubMed ID: 10884952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indirect assessment of confounding: graphic description and limits on effect of adjusting for covariates.
    Flanders WD; Khoury MJ
    Epidemiology; 1990 May; 1(3):239-46. PubMed ID: 2081259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relative efficiencies of matched and independent sample designs for case-control studies.
    Thomas DC; Greenland S
    J Chronic Dis; 1983; 36(10):685-97. PubMed ID: 6630405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methodological Quality of Surgical Mortality Studies Using Large Hospital Databases: A Systematic Review.
    Payet C; Lifante JC; Carty MJ; Rabilloud M; Duclos A
    Ann Surg; 2017 Jun; 265(6):1113-1118. PubMed ID: 28027060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug utilization statistics for individual-level pharmacy dispensing data.
    Hallas J
    Pharmacoepidemiol Drug Saf; 2005 Jul; 14(7):455-63. PubMed ID: 15651088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selection of controls in case-control studies. I. Principles.
    Wacholder S; McLaughlin JK; Silverman DT; Mandel JS
    Am J Epidemiol; 1992 May; 135(9):1019-28. PubMed ID: 1595688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.